Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Rujescu

Showing results (291-300 of 480) with videos related to

Pageof 48
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2009
Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cellsJens Benninghoff, Angela Gritti, Matteo Rizzi, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Journal of Psychiatric Research|November 24, 2015
Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophreniaOlaoluwa Okusaga, Erica Duncan, Patricia Langenberg, et al.
Plos One|February 18, 2010
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collectionsEnrico Domenici, David R Willé, Federica Tozzi, et al.
Fluids and Barriers of the CNS|November 1, 2023
Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer diseaseUndine Haferkamp, Carla Hartmann, Chaudhry Luqman Abid, et al.
JAMA Psychiatry|August 28, 2014
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer diseaseRonald Lautner, Sebastian Palmqvist, Niklas Mattsson, et al.
Journal of Psychiatric Research|July 23, 2013
CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging studyChristian Clemm von Hohenberg, Marlene C Wigand, Marek Kubicki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 14, 2017
Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working MemoryDonna Cosgrove, Omar Mothersill, Kimberley Kendall, et al.
The International Journal of Neuropsychopharmacology|November 10, 2024
Anhedonia is associated with a specific depression profile and poor antidepressant responseAntonina Luca, Maria Luca, Siegfried Kasper, et al.
Human Molecular Genetics|November 16, 2007
Strong evidence that GNB1L is associated with schizophreniaNigel M Williams, Beate Glaser, Nadine Norton, et al.
Pageof 48

Showing results (291-300 of 480) with videos related to

Sort By:
Pageof 48
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2009
Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cellsJens Benninghoff, Angela Gritti, Matteo Rizzi, et al.
Schizophrenia Bulletin|March 20, 2015
The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychoticsStefan Leucht, Inge Winter-van Rossum, Stephan Heres, et al.
Journal of Psychiatric Research|November 24, 2015
Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophreniaOlaoluwa Okusaga, Erica Duncan, Patricia Langenberg, et al.
Plos One|February 18, 2010
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collectionsEnrico Domenici, David R Willé, Federica Tozzi, et al.
Fluids and Barriers of the CNS|November 1, 2023
Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer diseaseUndine Haferkamp, Carla Hartmann, Chaudhry Luqman Abid, et al.
JAMA Psychiatry|August 28, 2014
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer diseaseRonald Lautner, Sebastian Palmqvist, Niklas Mattsson, et al.
Journal of Psychiatric Research|July 23, 2013
CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging studyChristian Clemm von Hohenberg, Marlene C Wigand, Marek Kubicki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 14, 2017
Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working MemoryDonna Cosgrove, Omar Mothersill, Kimberley Kendall, et al.
The International Journal of Neuropsychopharmacology|November 10, 2024
Anhedonia is associated with a specific depression profile and poor antidepressant responseAntonina Luca, Maria Luca, Siegfried Kasper, et al.
Human Molecular Genetics|November 16, 2007
Strong evidence that GNB1L is associated with schizophreniaNigel M Williams, Beate Glaser, Nadine Norton, et al.
Pageof 48